SynAct Pharma AB (SYNACT) — Cash Flow Reinvestment Rate
Latest as of June 2019:
0.22x
SynAct Pharma AB (SYNACT) has a Cash Flow Reinvestment Rate of 0.22x as of June 2019, reinvesting Skr394.90K (capex Skr394.90K ) from operating cash flow of Skr1.77 Million. Explore SynAct Pharma AB capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.22x
(Capex + Investments) / Operating CF
Total Reinvested
Skr394.90K
Capex + Investments
Operating Cash Flow
Skr1.77 Million
SEK
Capital Expenditures
Skr394.90K
SEK
Annual Cash Flow Reinvestment Rate for SynAct Pharma AB (None–None)
Year-by-year capital reinvestment analysis for SynAct Pharma AB. For live market cap and broader valuation context, see SYNACT company net worth.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow